Medicaid Monitor
Policy Intelligence
Medicaid Monitor
Policy Intelligence
© 2026 Lanphier Ventures, LLC
Informational use only. Not legal or compliance advice.
← All stories
Federal Policy·June 25, 2026

Bipartisan Bill Would Allow Direct Methadone Prescribing for Opioid Use Disorder

A bipartisan bill in Congress would end the requirement that methadone for opioid use disorder be dispensed only through specialty opioid treatment programs, allowing qualified practitioners to prescribe it directly like buprenorphine. The legislation would enable office-based prescribing and pharmacy dispensing of methadone, dramatically expanding access beyond the current clinic-only model. If enacted, the change would remove a longstanding barrier to medication-assisted treatment that has limited access particularly in rural and underserved areas. The timing and specific requirements for prescriber qualifications remain unclear pending legislative details.

Why it matters for managed care

Medicaid managed care organizations would need to credential new methadone prescribers, establish pharmacy networks capable of dispensing methadone, update prior authorization protocols, and potentially renegotiate rates as treatment shifts from specialized clinics to office-based settings.

Behavioral Health · Managed Care · Pharmacy

Read the full article at statnews.com

Share this briefing

You might also like

← All stories

Get the daily briefing.